These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29999491)

  • 1. How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion.
    Chao LH; Jang J; Johnson A; Nguyen A; Gray NS; Yang PL; Harrison SC
    Elife; 2018 Jul; 7():. PubMed ID: 29999491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential conformational rearrangements in flavivirus membrane fusion.
    Chao LH; Klein DE; Schmidt AG; Peña JM; Harrison SC
    Elife; 2014 Dec; 3():e04389. PubMed ID: 25479384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the identification of dengue virus entry/fusion inhibitors.
    De La Guardia C; Lleonart R
    Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate.
    Schmidt AG; Yang PL; Harrison SC
    PLoS Pathog; 2010 Apr; 6(4):e1000851. PubMed ID: 20386713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide inhibitors of dengue virus and West Nile virus infectivity.
    Hrobowski YM; Garry RF; Michael SF
    Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule inhibitors of dengue-virus entry.
    Schmidt AG; Lee K; Yang PL; Harrison SC
    PLoS Pathog; 2012; 8(4):e1002627. PubMed ID: 22496653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
    Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small molecule fusion inhibitor of dengue virus.
    Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
    Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
    J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate-related inhibitors of dengue virus entry.
    Hidari KI; Abe T; Suzuki T
    Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small-molecule dengue virus entry inhibitor.
    Wang QY; Patel SJ; Vangrevelinghe E; Xu HY; Rao R; Jaber D; Schul W; Gu F; Heudi O; Ma NL; Poh MK; Phong WY; Keller TH; Jacoby E; Vasudevan SG
    Antimicrob Agents Chemother; 2009 May; 53(5):1823-31. PubMed ID: 19223625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein.
    Liao M; Sánchez-San Martín C; Zheng A; Kielian M
    J Virol; 2010 Jun; 84(11):5730-40. PubMed ID: 20335260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavivirus cell entry and membrane fusion.
    Smit JM; Moesker B; Rodenhuis-Zybert I; Wilschut J
    Viruses; 2011 Feb; 3(2):160-171. PubMed ID: 22049308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of endosomal-membrane association for the dengue virus envelope protein.
    Rogers DM; Kent MS; Rempe SB
    Biochim Biophys Acta; 2015 Apr; 1848(4):1041-52. PubMed ID: 25559317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.
    Liu HY; Li Z; Reindl T; He Z; Qiu X; Golden RP; Donovan KA; Bailey A; Fischer ES; Zhang T; Gray NS; Yang PL
    Nat Commun; 2024 Jun; 15(1):5179. PubMed ID: 38898037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
    John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
    Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
    Chin JF; Chu JJ; Ng ML
    Microbes Infect; 2007 Jan; 9(1):1-6. PubMed ID: 17196419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.